|Day Low/High||276.44 / 282.56|
|52 Wk Low/High||250.21 / 342.26|
Washington will offer mixed bag answers to key policy questions.
Earnings beat down government headwinds, expect more gains ahead.
Let's take a peek at overnight and early-morning price action in some of the major asset classes. The rundown: S&P futures +5; Nasdaq +24, as Apple (AAPL) moves in after-hours trading; Nikkei -; European markets +; crude flat; gold +$5; and 10-year ...
Chase Growth Fund portfolio manager Edward Painvin names his favorite stocks including Visa, Actavis, Thermo Fisher and Precision Castparts.
John Toohey, PM of the USAA First Start Growth Fund, names his top stocks including AbbVie, Thermo Fisher, Google and Texas Instruments.
Banking giant Citigroup topped Wall Street forecasts by six cents a share on stronger securities and investment banking revenue. TheStreet's Brittany Umar has details from New York.
This recent laggard looks set for a turnaround, making it a good value at current levels.
Its CEO buys more shares, but some of the company's peers trade at better P/E multiples.
In the healthcare sector, TMO and TEVA are well positioned to ride out the market's current volatility.
This is a great opportunity to buy a stable growth stock at a discounted price.
Here's your second shot at Thermo Fisher, which has followed the market down to bargain prices.
After Wednesday's selloff, this very healthy growth name is selling for cheap.